Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer - PubMed (original) (raw)
. 1994 Nov 1;84(9):2868-77.
Affiliations
- PMID: 7949162
Free article
Selection of retrovirally transduced hematopoietic cells using CD24 as a marker of gene transfer
R Pawliuk et al. Blood. 1994.
Free article
Abstract
We have investigated the use of a cell surface antigen as a dominant selectable marker to facilitate the detection and selection of retrovirally infected target cells. The small coding region of the human cell surface antigen CD24 (approximately 240 bp) was introduced into a myeloproliferative sarcoma virus (MPSV)-based retroviral vector, which was then used to infect day 4 5-fluorouracil (5-FU)-treated murine bone marrow cells. Within 48 hours of termination of the infection procedure CD24-expressing cells were selected by fluorescent-activated cell sorting (FACS) with an antibody directed against the CD24 antigen. Functional analysis of these cells showed that they included not only in vitro clonogenic progenitors and day 12 colony-forming unit-spleen but also cells capable of competitive long-term hematopoietic repopulation. Double-antibody labeling studies performed on recipients of retrovirally transduced marrow cells showed that some granulocytes, macrophages, erythrocytes, and, to a lesser extent, B and T lymphocytes still expressed the transduced CD24 gene at high levels 4 months later. No gross abnormalities in hematopoiesis were detected in mice repopulated with CD24-expressing cells. Our results show that the use of the CD24 cell surface antigen as a retrovirally encoded marker enables the rapid, efficient, and nontoxic selection in vitro of infected primary cells, facilitates tracking and phenotyping of their progeny, and should provide a unique tool to identify elements that regulate the expression of transduced genes in the most primitive hematopoietic cells.
Similar articles
- Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transfer.
Conneally E, Bardy P, Eaves CJ, Thomas T, Chappel S, Shpall EJ, Humphries RK. Conneally E, et al. Blood. 1996 Jan 15;87(2):456-64. Blood. 1996. PMID: 8555466 - Sustained high-level reconstitution of the hematopoietic system by preselected hematopoietic cells expressing a transduced cell-surface antigen.
Pawliuk R, Eaves CJ, Humphries RK. Pawliuk R, et al. Hum Gene Ther. 1997 Sep 1;8(13):1595-604. doi: 10.1089/hum.1997.8.13-1595. Hum Gene Ther. 1997. PMID: 9322092 - Selection of transduced CD34+ progenitors and enzymatic correction of cells from Gaucher patients, with bicistronic vectors.
Migita M, Medin JA, Pawliuk R, Jacobson S, Nagle JW, Anderson S, Amiri M, Humphries RK, Karlsson S. Migita M, et al. Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12075-9. doi: 10.1073/pnas.92.26.12075. Proc Natl Acad Sci U S A. 1995. PMID: 8618847 Free PMC article. - Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer.
Clay TM, Custer MC, Spiess PJ, Nishimura MI. Clay TM, et al. Pathol Oncol Res. 1999;5(1):3-15. doi: 10.1053/paor.1999.0003. Pathol Oncol Res. 1999. PMID: 10079371 Review. - Selection of retrovirally transduced cells to enhance the efficiency of gene therapy.
Medin JA, Karlsson S. Medin JA, et al. Proc Assoc Am Physicians. 1997 Mar;109(2):111-9. Proc Assoc Am Physicians. 1997. PMID: 9069579 Review.
Cited by
- Development of improved adenosine deaminase retroviral vectors.
Onodera M, Nelson DM, Yachie A, Jagadeesh GJ, Bunnell BA, Morgan RA, Blaese RM. Onodera M, et al. J Virol. 1998 Mar;72(3):1769-74. doi: 10.1128/JVI.72.3.1769-1774.1998. J Virol. 1998. PMID: 9499026 Free PMC article. - Murine hematopoietic reconstitution after tagging and selection of retrovirally transduced bone marrow cells.
García-Hernández B, Castellanos A, López A, Orfao A, Sánchez-García I. García-Hernández B, et al. Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13239-44. doi: 10.1073/pnas.94.24.13239. Proc Natl Acad Sci U S A. 1997. PMID: 9371830 Free PMC article. - Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusions.
Yung E, Sekulovic S, Argiropoulos B, Lai CK, Leung M, Berg T, Vollett S, Chang VC, Wan A, Wong S, Humphries RK. Yung E, et al. Leuk Res. 2011 Apr;35(4):545-50. doi: 10.1016/j.leukres.2010.10.006. Epub 2010 Dec 3. Leuk Res. 2011. PMID: 21130494 Free PMC article. - Towards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapy.
Nagree MS, López-Vásquez L, Medin JA. Nagree MS, et al. World J Stem Cells. 2015 Dec 26;7(11):1233-50. doi: 10.4252/wjsc.v7.i11.1233. World J Stem Cells. 2015. PMID: 26730268 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical